Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - INOVIO PHARMACEUTICALS, INC. | ino-12312014x10kex231.htm |
| EX-31.2 - EX-31.2 - INOVIO PHARMACEUTICALS, INC. | ino-12312014x10kex312.htm |
| EX-31.1 - EX-31.1 - INOVIO PHARMACEUTICALS, INC. | ino-12312014x10kex311.htm |
| EX-32.1 - EX-32.1 - INOVIO PHARMACEUTICALS, INC. | ino-12312014x10kex321.htm |
| EX-10.12 - EX-10.12 - INOVIO PHARMACEUTICALS, INC. | ino-12312014x10kex1012.htm |
| EXCEL - IDEA: XBRL DOCUMENT - INOVIO PHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - 10-K - INOVIO PHARMACEUTICALS, INC. | ino-12312014x10k.htm |
Exhibit 21.1
INOVIO PHARMACEUTICALS, INC.
Subsidiaries
Subsidiary Name(1) | Jurisdiction of Organization | |||
Genetronics, Inc. | California | |||
VGX Pharmaceuticals, LLC | Delaware | |||
VGX Animal Health, Inc. | Delaware | |||
(1) | In accordance with Instructions (ii) to Exhibit (21) to the Exhibit Table in Item 601 of Regulation S-K, Registrant has omitted from the above table one of its subsidiaries because such omitted subsidiary does not constitute a significant subsidiary of registrant as of the end of the year covered by this report. |